326 related articles for article (PubMed ID: 23245687)
1. Complications and early postoperative outcome in 1080 patients after thulium vapoenucleation of the prostate: results at a single institution.
Gross AJ; Netsch C; Knipper S; Hölzel J; Bach T
Eur Urol; 2013 May; 63(5):859-67. PubMed ID: 23245687
[TBL] [Abstract][Full Text] [Related]
2. A prospective, randomized trial comparing thulium vapoenucleation with holmium laser enucleation of the prostate for the treatment of symptomatic benign prostatic obstruction: perioperative safety and efficacy.
Netsch C; Becker B; Tiburtius C; Moritz C; Becci AV; Herrmann TRW; Gross AJ
World J Urol; 2017 Dec; 35(12):1913-1921. PubMed ID: 28698991
[TBL] [Abstract][Full Text] [Related]
3. 120-W 2-µm thulium:yttrium-aluminium-garnet vapoenucleation of the prostate: 12-month follow-up.
Netsch C; Pohlmann L; Herrmann TR; Gross AJ; Bach T
BJU Int; 2012 Jul; 110(1):96-101. PubMed ID: 22085294
[TBL] [Abstract][Full Text] [Related]
4. Thulium vapoenucleation of the prostate versus holmium laser enucleation of the prostate for the treatment of large volume prostates: preliminary 6-month safety and efficacy results of a prospective randomized trial.
Becker B; Herrmann TRW; Gross AJ; Netsch C
World J Urol; 2018 Oct; 36(10):1663-1671. PubMed ID: 29730838
[TBL] [Abstract][Full Text] [Related]
5. Thulium laser (Revolix) vapoenucleation of the prostate is a safe procedure in patients with an increased risk of hemorrhage.
Hauser S; Rogenhofer S; Ellinger J; Strunk T; Müller SC; Fechner G
Urol Int; 2012; 88(4):390-4. PubMed ID: 22627127
[TBL] [Abstract][Full Text] [Related]
6. Thulium laser (RevoLix) vaporesection versus vapoenucleation with morcellator (Piranha) for the treatment of benign prostatic obstruction: a propensity-matched multicenter analysis.
Chung JS; Kang PM; Seo WI; Oh CK; Kim SC; Park SH; Choi JH; Yoon JH; Kang DI; Chung JI
Int J Urol; 2014 Nov; 21(11):1156-61. PubMed ID: 25040293
[TBL] [Abstract][Full Text] [Related]
7. Five-year outcomes of thulium vapoenucleation of the prostate for symptomatic benign prostatic obstruction.
Gross AJ; Orywal AK; Becker B; Netsch C
World J Urol; 2017 Oct; 35(10):1585-1593. PubMed ID: 28405763
[TBL] [Abstract][Full Text] [Related]
8. [Thulium vapoenucleation of prostates larger than 80 ml using a 1.9-µm and a 2-µm thulium laser. Early perioperative results from two centres].
Netsch C; Knoll T; Gross AJ; Wendt-Nordahl G
Urologe A; 2015 Oct; 54(10):1414-20. PubMed ID: 25312754
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and safety of 120-W thulium:yttrium-aluminum-garnet vapoenucleation of prostates compared with holmium laser enucleation of prostates for benign prostatic hyperplasia.
Hong K; Liu YQ; Lu J; Xiao CL; Huang Y; Ma LL
Chin Med J (Engl); 2015 Apr; 128(7):884-9. PubMed ID: 25836607
[TBL] [Abstract][Full Text] [Related]
10. A comparative study of thulium laser resection of the prostate and bipolar transurethral plasmakinetic prostatectomy for treating benign prostatic hyperplasia.
Peng B; Wang GC; Zheng JH; Xia SQ; Geng J; Che JP; Yan Y; Huang JH; Xu YF; Yang B
BJU Int; 2013 Apr; 111(4):633-7. PubMed ID: 23107074
[TBL] [Abstract][Full Text] [Related]
11. A prospective, randomized comparison of a 1940 nm and a 2013 nm thulium: yttrium-aluminum-garnet laser device for Thulium VapoEnucleation of the prostate (ThuVEP): First results.
Tiburtius C; Gross AJ; Netsch C
Indian J Urol; 2015; 31(1):47-51. PubMed ID: 25624576
[TBL] [Abstract][Full Text] [Related]
12. Bipolar plasma enucleation of the prostate vs open prostatectomy in large benign prostatic hyperplasia cases - a medium term, prospective, randomized comparison.
Geavlete B; Stanescu F; Iacoboaie C; Geavlete P
BJU Int; 2013 May; 111(5):793-803. PubMed ID: 23469933
[TBL] [Abstract][Full Text] [Related]
13. Thulium:YAG VapoEnucleation of the prostate in large glands: a prospective comparison using 70- and 120-W 2-µm lasers.
Netsch C; Bach T; Herrmann TR; Gross AJ
Asian J Androl; 2012 Mar; 14(2):325-9. PubMed ID: 22231295
[TBL] [Abstract][Full Text] [Related]
14. Comparison of 120-200 W 2 μm thulium:yttrium-aluminum-garnet vapoenucleation of the prostate.
Netsch C; Bach T; Pohlmann L; Herrmann T; Gross AJ
J Endourol; 2012 Mar; 26(3):224-9. PubMed ID: 22191688
[TBL] [Abstract][Full Text] [Related]
15. Thulium:YAG vapoenucleation in large volume prostates.
Bach T; Netsch C; Pohlmann L; Herrmann TR; Gross AJ
J Urol; 2011 Dec; 186(6):2323-7. PubMed ID: 22014812
[TBL] [Abstract][Full Text] [Related]
16. One day surgery in the treatment of benign prostatic enlargement with thulium laser: A single institution experience.
Carmignani L; Macchi A; Ratti D; Finkelberg E; Casellato S; Maruccia S; Marenghi C; Picozzi SC
Korean J Urol; 2015 May; 56(5):365-9. PubMed ID: 25964837
[TBL] [Abstract][Full Text] [Related]
17. Vapoenucleation of the prostate using a high-power thulium laser: a one-year follow-up study.
Chang CH; Lin TP; Chang YH; Huang WJ; Lin AT; Chen KK
BMC Urol; 2015 May; 15():40. PubMed ID: 25956819
[TBL] [Abstract][Full Text] [Related]
18. A prospective analysis of thulium laser enucleation in benign prostatic hyperplasia comparing low- and high-power approaches for prostates exceeding 80 g.
Abdelaziz AY; Kamal I; Abdelhakim MA; Abdelmohsen M; Meshref A; Naser I; Morsy S
World J Urol; 2024 Apr; 42(1):265. PubMed ID: 38676756
[TBL] [Abstract][Full Text] [Related]
19. Analysis of early morbidity and functional outcome of thulium: yttrium-aluminum-garnet laser enucleation for benign prostate enlargement: patient age and prostate size determine adverse surgical outcome.
Rausch S; Heider T; Bedke J; Kruck S; Schwentner C; Fischer K; Stenzl A; Kälble T
Urology; 2015 Jan; 85(1):182-8. PubMed ID: 25530383
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of the learning curve for Thulium VapoEnucleation of the prostate (ThuVEP) using a mentor-based approach.
Netsch C; Bach T; Herrmann TR; Neubauer O; Gross AJ
World J Urol; 2013 Oct; 31(5):1231-8. PubMed ID: 22733237
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
